BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 10, 2026
Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

Survey: communication regarding imaging for older patients lacking

Feb. 19, 2010
By Omar Ford

Calypso GPS system receives validation through clinical study

Feb. 18, 2010
By Omar Ford
The Holy Grail for those treating cancer patients is to be able to successfully eliminate tumors with radiotherapy without impacting vital organs that surround the growths. The problem has always been that the affected areas often move or shift due to a variety of different reasons. While the movement might be less than a millimeter, that shift can throw off therapy and cause some unwanted side affects. (Medical Device Daily)
Read More

Colorectal cancer rate disparity growing between blacks, whites

Feb. 17, 2010
By Omar Ford

Salyer, Medtronic in distribution for Century Heart Lung device

Feb. 16, 2010
By Omar Ford
When Jeff Poland and Nancy Salyer first purchased the Century Heart-Lung Machine back in 2004, the two thought that some Internet marketing, an internal sales team, and a strong product was all they needed to be successful on the market with the device. (Medical Device Daily)
Read More

Report: China's healthcare spending to reach $600B by 2015

Feb. 12, 2010
By Omar Ford
The U.S. isn't the only nation that's in the process of undergoing some sort of healthcare reform. A report commissioned by Scientia Advisors (Cambridge, Massachusetts), shows that healthcare spending in China is expected to reach $600 billion by 2015 – a threefold increase from 2000. It's a change that the company is saying will drastically alter the healthcare landscape for the country. (Medical Device Daily)
Read More

Biomagnetics Diagnostics on right path with IOB platform

Feb. 11, 2010
By Omar Ford
Entry into the med-tech industry was neither simple nor easy for former Navy Seal and current CEO of Biomagnetics Diagnostics (San Francisco) Clayton Hardman. (Medical Device Daily)
Read More

Sanuwave's dermaPACE gets favorable results in study

Feb. 10, 2010
By Omar Ford

EchoMetrics offers cardiologists echocardiogram interpretation

Feb. 9, 2010
By Omar Ford

Spectranetics reveals 'favorable' study results for Lexicon

Feb. 8, 2010
By Omar Ford

Study shows men fare better in AF procedures than women

Feb. 5, 2010
By Omar Ford
View All Articles by Omar Ford

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Art concept for inflammation in the intestines

    Kymera’s IRF5 degrader shows potential in IBD treatment

    BioWorld Science
    At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing